fr

CARMAT announces its 2023 annual results and provides an update on its progress and prospects for 2024

Annual results in line with expectations

Download

CARMAT_appoints Valerie Leroy as Director of Marketing and IR

Download

CARMAT receives payment of over Ç4 million in public financia support

Download

CARMAT_appoints Henri Lachmann _to _its Board of Directors

Download

Assembly of the first clinical version of the artificial heart

Download

Agreement with Edwards Lifesciences

Download

Half year results

Download

CARMAT announces the success of its IPO

Download
Top of page